Timing of preemptive vascular access placement: do we understand the natural history of advanced CKD?: an observational study

BMC Nephrology

Chi-yuan Hsu¹  Kirsten L Johansen¹  Daniel P Murphy¹  Chenyin He¹  Nisha Bansal¹ 

[1] Division of Nephrology, University of California, San Francisco, 521 Parnassus Ave, Box 0532, San Francisco, CA, 94143, USA

关键词: Progression;    ESRD;    Dialysis;    AVF;    Advanced CKD;   

Others  :  1082924
DOI  :  10.1186/1471-2369-14-115

 received in 2013-02-01, accepted in 2013-05-21,  发布年份 2013

【 摘 要 】

Background

Little is known about the targets and expectations of practicing nephrologists with regard to timing of preemptive AV access surgery and how these relate to actual observed practice patterns in clinical care.

Methods

We administered a 8-question survey to assess nephrologists’ expectations for preemptive vascular access placement to 53 practicing nephrologists in California. We performed a retrospective chart review of 116 patients who underwent preemptive vascular access placement at a large academic medical center and examined progression to ESRD.

Results

According to our survey of nephrologists, most aimed to have preemptive vascular access created about 6 months prior to start of ESRD or when the chances of ESRD within the next year is two-thirds or greater. The estimated GFR level at which they believe match these conditions is approximately 18 ml/min/1.73 m². Among the 116 patients with CKD who underwent preemptive vascular access creation, the mean estimated GFR at the time of access creation was 16.1 (6.8) ml/min/1.73 m². Only 57 out of the 116 patients (49.1%) patients initiated maintenance HD within 1 year after surgery.

Conclusions

In our study, most nephrologists aim for preemptive vascular access surgery approximately 6 months prior to the start of HD. However in fact, only approximately 50% of patients who underwent preemptive vascular access surgery started HD within 1 year. Better tools are needed to predict the natural history of advanced CKD.

【 授权许可】

   
2013 Bansal et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Xue JL, Dahl D, Ebben JP, Collins AJ: The association of initial hemodialysis access type with mortality outcomes in elderly Medicare ESRD patients. Am J Kidney Dis 2003, 42(5):1013-1019.
• [2]Astor BC, Eustace JA, Powe NR, Klag MJ, Fink NE, Coresh J: Type of vascular access and survival among incident hemodialysis patients: the choices for healthy outcomes in caring for ESRD (CHOICE) study. J Am Soc Nephrol 2005, 16(5):1449-1455.
• [3]Fistula First. http://www.fistulafirst.org webcite
• [4]Murad MH, Sidawy AN, Elamin MB, Rizvi AZ, Flynn DN, McCausland FR, McGrath MM, Vo DH, El-Zoghby Z, Casey ET, Duncan AA, Tracz MJ, Erwin PJ, Montori VM: Timing of referral for vascular access placement: a systematic review. J Vasc Surg 2008, 48(5 Suppl):31S-33S.
• [5]Sidawy AN, Spergel LM, Besarab A, Allon M, Jennings WC, Padberg FT, Murad MH, Montori VM, O’Hare AM, Calligaro KD, Macsata RA, Lumsden AB, Ascher E: The society for vascular surgery: clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access. J Vasc Surg 2008, 48:2S-25S.
• [6]Jindal K, Chan CT, Deziel C, Hirsch D, Soroka SD, Tonelli M, Culleton BF: Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology. J Am Soc Nephrol 2006, 17(3 Suppl 1):S1-S27.
• [7]Canadian Society of N: Report of the canadian society of nephrology vascular access working group. Semin Dial 2012, 25(1):22-25.
• [8]III. NKF-K/DOQI clinical practice guidelines for vascular access: update 2000 Am J Kidney Dis 2001, 37(1 Suppl 1):S137-S181.
• [9]NKF-K/DOQI clinical practice guidelines and clinical practice recommendations 2006 updates: vascular access. http://www.kidney.org/professionals/kdoqi/guideline_uphd_pd_va webcite
• [10]Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F: Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006, 145(4):247-254.
• [11]Tangri N, Stevens LA, Griffith J, Tighiouart H, Djurdjev O, Naimark D, Levin A, Levey AS: A predictive model for progression of chronic kidney disease to kidney failure. JAMA 2011, 305(15):1553-1559.
• [12]O’Hare AM, Bertenthal D, Walter LC, Garg AX, Covinsky K, Kaufman JS, Rodriguez RA, Allon M: When to refer patients with chronic kidney disease for vascular access surgery: should age be a consideration? Kidney Int 2007, 71(6):555-561.
• [13]Weber CL, Djurdjev O, Levin A, Kiaii M: Outcomes of vascular access creation prior to dialysis: building the case for early referral. ASAIO J 2009, 55(4):355-360.
• [14]Kimball TA, Barz K, Dimond KR, Edwards JM, Nehler MR: Efficiency of the kidney disease outcomes quality initiative guidelines for preemptive vascular access in an academic setting. J Vasc Surg 2011, 54(3):760-765. discussion 765–766
• [15]Oliver MJ, Quinn RR, Garg AX, Kim SJ, Wald R, Paterson JM: Likelihood of starting dialysis after incident fistula creation. Clin J Am Soc Nephrol 2012, 7(3):466-471.
• [16]Levin A, Djurdjev O, Beaulieu M, Er L: Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort. Am J Kidney Dis 2008, 52(4):661-671.
• [17]O’Hare AM, Choi AI, Bertenthal D, Bacchetti P, Garg AX, Kaufman JS, Walter LC, Mehta KM, Steinman MA, Allon M, McClellan WM, Landefeld CS: Age affects outcomes in chronic kidney disease. J Am Soc Nephrol 2007, 18(10):2758-2765.
• [18]Li L, Astor BC, Lewis J, Hu B, Appel LJ, Lipkowitz MS, Toto RD, Wang X, Wright JT Jr, Greene TH: Longitudinal progression trajectory of GFR among patients with CKD. Am J Kidney Dis 2012, 59(4):504-512.
• [19]Hemmelgarn BR, James MT, Manns BJ, O’Hare AM, Muntner P, Ravani P, Quinn RR, Turin TC, Tan Z, Tonelli M, Alberta Kidney Disease N: Rates of treated and untreated kidney failure in older vs younger adults. Jama 2012, 307(23):2507-2515.
• [20]KDIGO international guidelines. http://www.kdigo.org/clinical_practice_guidelines/CKD.php webcite
• [21]Collins J, Cooper B, Branley P, Bulfone L, Craig J, Fraenkel M, Harris A, Johnson D, Kesselhut J, Li JJ, Luxton G, Pilmore A, Tiller D, Harris D, Pollock C: Outcomes of patients with planned initiation of hemodialysis in the IDEAL trial. Contrib Nephrol 2011, 171:1-9.
• [22]Cooper BA, Branley P, Bulfone L, Collins JF, Craig JC, Fraenkel MB, Harris A, Johnson DW, Kesselhut J, Li JJ, Luxton G, Pilmore A, Tiller DJ, Harris DC, Pollock CA, IDEAL Study: A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med 2010, 363(7):609-619.
• [23]Parker TF 3rd, Straube BM, Nissenson A, Hakim RM, Steinman TI, Glassock RJ: Dialysis at a crossroads–part II: a call for action. Clin J Am Soc Nephrol 2012, 7(6):1026-1032.